Slobodan Obradovic

Slobodan Obradovic

Auto-generated profile, based on publicly available information

Slobodan Obradovic

Pedijatrijska klinika, Klinički centar, Kragujevac

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2016 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
Natasa DjordjevicNatasa Djordjevic
Natasa Djordjevic
DMDragana Dragas Milovanovic
Dragana Dragas Milovanovic
MRMarija Radovanovic
Marija Radovanovic
IRIvan Radosavljevic
Ivan Radosavljevic
SOSlobodan Obradovic
Slobodan Obradovic
SJSlobodan Jankovic
Slobodan Jankovic

1 June 2015 in Serbian Journal of Experimental and Clinical Research
Verified
Journal Article
Open access
PDF file
DMDragana Dragas Milovanovic
Dragana Dragas Milovanovic
IRIvan Radosavljevic
Ivan Radosavljevic
MRMarija Radovanovic
Marija Radovanovic
JMJasmina Milovanovic
Jasmina Milovanovic
SOSlobodan Obradovic
Slobodan Obradovic
Natasa DjordjevicNatasa Djordjevic
Natasa Djordjevic
Carbamazepine exhibits significant inter-individual variability in its efficacy and safety, which leads to unpredictable therapy outcomes for the majority of patients. Although its complex biotransformation depends on CYP3A5 activity, evidence of association between carbamazepine treatment outcomes and CYP3A5 functional variations remains inconclusive. The aim of the present study was to investigate the distribution of two of the functionally important CYP3A5 variants *2 and *3 as well as their effects on carbamazepine dose requirements, plasma concentrations and clearance in a Serbian population. The study involved 40 paediatric epileptic patients on steady-state carbamazepine treatment. Genotyping was conducted using the PCR-RFLP method, and carbamazepine plasma concentrations were determined using the HPLC method. CYP3A5*2 and *3 polymorphisms were found at frequencies of 0.0% and 97.5%, respectively, which corresponds well to previously published data for Caucasians. No differences in CYP3A5*3 allele frequencies were detected among epileptic patients in comparison to healthy volunteers within similar ethnic populations (p>0.08), indicating that CYP3A5 polymorphism does not represent a risk factor for epilepsy development. There was an observed tendency towards lower dosage requirements (mean±SD: 15.06±4.45 mg/kg vs. 18.74±5.55 mg/kg; p=0.26), higher plasma concentrations (mean±SD: 0.45±0.13 mg/kg vs. 0.38±0.03 mg/kg; p=0.47) and lower clearance (mean±SD: 0.14±0.05 mg/kg vs. 0.15±0.01 mg/kg; p=0.79) of carbamazepine in homozygous carriers of CYP3A5*3/*3 compared to heterozygous CYP3A5*1A/*3 Serbians. Because these genotype groups did not differ significantly in terms of their carbamazepine pharmacokinetics parameters, the proposed effects of CYP3A5*3 on carbamazepine metabolism could not be confirmed.

7 January 2015 in Neuroepidemiology
Verified
Journal Article
Closed access
ASAdrijan Sarajlija
Adrijan Sarajlija
DKDarija Kisic-Tepavcevic
Darija Kisic-Tepavcevic
ZNZorana Nikolic
Zorana Nikolic
DSDusanka Savic-Pavicevic
Dusanka Savic-Pavicevic
SOSlobodan Obradovic
Slobodan Obradovic
TPTatjana Pekmezovic
Tatjana Pekmezovic
Background: Rett syndrome (RTT) is a severe neurodevelopmental disorder that represents the second most common cause of mental retardation in females. However, incidence and prevalence of RTT are scarcely reported. Methods: A retrospective study included all patients with RTT diagnosed between 1981 and 2012 in Serbia. Estimation of incidence and prevalence was calculated on the basis of vital statistics reported by Statistical Office of Republic of Serbia. Results: From 1981 to 2012, RTT has been diagnosed in 102 girls in Serbia. Incidence of RTT in Serbia is estimated at 0.586:10,000 female live births. We estimated the prevalence of RTT in population of females younger than 19 years at 1:8,439. Death occurred in 19 patients (18.63%), with pneumonia as the most common cause. The lethal outcome by the age of 12 years could be expected for 11% of patients. The mean age at diagnosis was 3.5 years and we have confirmed a significant trend towards earlier dianosis during studied period. Conclusions: Rett syndrome incidence in Serbia is in accordance with reports from other countries. Serbian RTT patients have increased risk for early death when compared to patients in more developed countries, most commonly due to pneumonia. There was significant trend towards early diagnosis of RTT in Serbia over recent decades.

1 January 2013 in Vojnosanitetski Pregled
Verified
Journal Article
Open access
PDF file
VJVladimir Janjic
Vladimir Janjic
DMDragan R. Milovanović
Dragan R. Milovanović
DRDejana Ruzic-Zecevic
Dejana Ruzic-Zecevic
DLDragan Loncar
Dragan Loncar
OLOlivera Laban
Olivera Laban
SJSlobodan Janković
Slobodan Janković
Introduction. Almost all individual antipsychotics are classified into the intermediate pregnancy risk category as no or limited data exist about human pregnancy outcomes. We presented the case of zuclopenthixol decanoate using in two successive pregnancies of the same woman, which had not been published in the available peer-reviewed literature. Case report. A middle-age female subject who suffered from schizophrenia received zuclopenthixol decanoate injection during her two consecutive pregnancies. About four and a half months before diagnosis of the first pregnancy (~3.5 years after psychosis emergence), zuclopenthixol decanoate (400 mg every other week, im injection) was introduced to the treatment protocol (due to previous non-compliance with haloperidol and risperidone). A significant clinical improvement was achieved and the dose during pregnancy was reduced to 200 mg once monthly and maintained to date. In both pregnancies the women gave birth to healthy girls who have been developing normally until now, at their ages of 6 months and of 3.5 years. During pregnancy and after giving birth to children the mothers? psychiatric status and her social functioning were significantly improved and are still stable. Close monitoring of the mother?s health, a multidisciplinary approach to both her treatment and the monitoring of pregnancies as well as the complete compliance with the prescribed drug protocol were likely to be crucial for the therapeutic success. Conclusion. A favorable outcome of the present case suggests that the zuclopenthixol decanoate is a rational therapeutic option for pregnant women suffering from psychosis when the expected benefit exceed the potential risk, but a definitive evidence for its safety requires large, controlled studies.

1 June 2016 in Balkan Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
DMDd Milovanovic
Dd Milovanovic
JMJasmina Milovanovic
Jasmina Milovanovic
MRM Radovanovic
M Radovanovic
IRIvan Radosavljevic
Ivan Radosavljevic
SOS Obradovic
S Obradovic
Natasa DjordjevicNatasa Djordjevic
Natasa Djordjevic
The aim of the present study was to investigate the distribution of CYP2C8 variants *3 and *5, as well as their effect on carbamazepine pharmacokinetic properties, in 40 epileptic pediatric patients on carbamazepine treatment. Genotyping was conducted using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), and allele-specific (AS)-PCR methods, and steady-state carbamazepine plasma concentrations were determined by high performance liquid chromatography (HPLC). The CYP2C8 *3 and *5 polymorphisms were found at frequencies of 17.5 and 0.0%, respectively. After dose adjustment, there was a difference in daily dose in CYP2C8*3 carriers compared to non carriers [mean ± standard deviation (SD): 14.19 ± 5.39 vs. 15.46 ± 4.35 mg/kg; p = 0.5]. Dose-normalized serum concentration of carbamazepine was higher in CYP2C8*3 (mean ± SD: 0.54 ± 0.18 vs. 0.43 ± 0.11 mg/mL, p = 0.04), and the observed correlation between weight-adjusted carbamazepine dose and carbamazepine concentration after dose adjustment was significant only in CYP2C8*3 non carriers (r = 0.52, p = 0.002). However, the population pharmacokinetic analysis failed to demonstrate any significant effect of CYP2C8 *3 polymorphism on carbamazepine clearance [CL L/h = 0.215 + 0.0696*SEX+ 0.000183*DD]. The results indicated that the CYP2C8*3 polymorphism might not be of clinical importance for epilepsy treatment in pediatric populations.

1 January 2013 in Srpski arhiv za celokupno lekarstvo
Verified
Journal Article
Open access
PDF file
ASAndjelka Stojkovic
Andjelka Stojkovic
NRNedeljko Radlovic
Nedeljko Radlovic
BVBiljana Vuletic
Biljana Vuletic
BNBranimir Nestorovic
Branimir Nestorovic
ZLZoran Lekovic
Zoran Lekovic
AVAna Vujic
Ana Vujic
Introduction. Cystic fibrosis (CF) is a multisystemic autosomal recessive disease most frequently recognized by characteristic respiratory and/or digestive manifestations. Exceptionally rare, as is the case with the infant we are presenting, the initial sign of the disease can be nutritional deficiency dermatitis (NDD). Case Outline. A three-month-old male infant of young and healthy non-consanguineous parents, born at term after the first uneventful pregnancy, was hospitalized due to atopic dermatitis (AD)-like skin changes, failure to thrive and normochromic anemia (Hb 60 g/L). As exclusively breast-fed, failure to thrive was attributed to hypogalactia and skin changes to nutritional allergy, so that, besides exclusion of cow?s milk protein and other highly allergenic foods in mother?s diet, hypoallergenic milk formula was added to the child?s diet. However, dietetic measures were without effect, and the child was re-hospitalized at age 4.5 months, this time in the condition of severe malnutrition with hypoproteinemic edemas, extensive dermatitis, moderate hepatosplenomegaly and recurrent normochromic anemia (Hb 57 g/L). After plasma-free erythrocyte transfusion, correction of hypoalbuminemia and two-week parenteral and semi-elementary nutrition resulted in gradual recovery of the child, also including the resolution of skin changes. Having in mind the clinical course of the disease, as well as the response to applied therapeutic measures, CF was suspected as the cause of the child?s problems, which was also confirmed by a high level of sweat chlorine (92 mmol/L) and DNA analysis (?F508/?F508). Conclusion. Our experience indicates that NDD, as the initial manifestation of CF, should be also kept in mind in differential diagnosis of the infant?s AD-like changes.